Splenic Infarction

Clinical Comprehensive Guide: Splenic Infarction

1. Comprehensive Introduction & Overview

Splenic infarction is a clinical condition characterized by the localized or diffuse necrosis of splenic tissue resulting from an interruption of blood supply. While the spleen is a highly vascularized organ—receiving approximately 5% of total cardiac output via the splenic artery—it is susceptible to ischemic events due to its terminal arterial supply structure.

Historically considered a rare clinical entity, advancements in diagnostic imaging, particularly contrast-enhanced computed tomography (CECT), have led to an increase in reported cases. The condition is rarely a primary pathology; rather, it is almost exclusively secondary to an underlying systemic disease, ranging from hematologic malignancies and embolic phenomena to connective tissue disorders and hypercoagulable states. Understanding splenic infarction requires a high index of suspicion, as the clinical presentation is often nonspecific and can mimic a variety of acute abdominal pathologies.

2. Deep-Dive: Etiology and Pathophysiology

The pathophysiology of splenic infarction centers on the compromise of the splenic artery or its distal branches. The spleen possesses a "wedge-shaped" vascular architecture, meaning that an occlusion of a terminal branch results in a characteristic wedge-shaped area of ischemia.

Primary Mechanisms of Ischemia

• Embolic Events: The most frequent cause. Emboli typically originate from the heart (e.g., atrial fibrillation, infective endocarditis, or mural thrombi post-myocardial infarction).
• In-Situ Thrombosis: Often associated with myeloproliferative neoplasms (e.g., Polycythemia Vera, Essential Thrombocythemia) or hypercoagulable states (Factor V Leiden, Protein C/S deficiency).
• Vascular Compression/Infiltration: Extrinsic compression by tumors, pancreatic pseudocysts, or vascular torsion (splenic volvulus).
• Hematologic Malignancies: Massive splenomegaly in leukemia or lymphoma can lead to relative ischemia, as the metabolic demand of the hyperplastic tissue outstrips the vascular supply.

Pathophysiological Stages

1. Phase I (Acute Ischemia): Sudden cessation of arterial flow. The parenchyma undergoes anaerobic metabolism, leading to cellular edema and loss of splenic architecture.
2. Phase II (Coagulative Necrosis): Within 24–48 hours, the ischemic tissue undergoes coagulative necrosis. The capsule remains intact, but the inflammatory response is triggered.
3. Phase III (Resolution or Complication): The necrotic area may either fibrose (forming a "scar") or liquefy, potentially leading to a splenic pseudocyst, abscess, or, in rare cases, hemorrhage/rupture.

3. Clinical Presentation and Diagnostic Evaluation

Standard Presentation

The classic presentation of splenic infarction is acute, sharp left upper quadrant (LUQ) pain, which may radiate to the left shoulder (Kehr’s sign) due to diaphragmatic irritation. However, presentation varies wildly:
* Asymptomatic: Small infarctions may be discovered incidentally on imaging.
* Acute Abdomen: Severe cases may present with peritoneal signs, fever, and tachycardia.
* Systemic Symptoms: Patients often present with symptoms of the underlying trigger (e.g., constitutional symptoms of malignancy or fever of endocarditis).

Key Diagnostic Tests

The gold standard for diagnosis is Contrast-Enhanced Computed Tomography (CECT) of the abdomen.

• CT Findings: Characterized by a wedge-shaped, hypoattenuating area within the splenic parenchyma. The base of the wedge is typically oriented toward the splenic capsule.
• Ultrasound: Useful in unstable patients (FAST exam), though less sensitive than CT. It may show ill-defined hypoechoic areas.
• MRI: Reserved for patients with contraindications to CT contrast or for characterizing complex lesions.
• Laboratory Analysis:
  • CBC: May show leukocytosis (inflammatory response) or abnormal cell counts (underlying malignancy).
  • LDH (Lactate Dehydrogenase): Often elevated, serving as a nonspecific marker of tissue necrosis.
  • Coagulation Profile: Essential to screen for hypercoagulable states.

4. Differential Diagnosis

Distinguishing splenic infarction from other acute abdominal pathologies is critical:
* Splenic Abscess: Usually presents with higher fever, leukocytosis, and a different rim-enhancing pattern on CT.
* Splenic Rupture: Usually associated with trauma; shows hemoperitoneum.
* Renal Colic: Pain is usually flank-based and radiates to the groin; hematuria is typically present.
* Myocardial Infarction: Inferior wall MI can present with upper abdominal pain.
* Pancreatitis: Elevated lipase and characteristic CT findings distinguish this from splenic infarction.

5. Management, Risks, and Prognosis

Therapeutic Strategy

Management is dictated by the severity of the infarction and the nature of the underlying cause.

1. Conservative Management: The cornerstone of treatment for stable patients. Includes:
   • Pain Control: Aggressive analgesia.
   • Hydration: Supportive care.
   • Anticoagulation: Indicated if an embolic source or hypercoagulable state is identified.
2. Surgical Intervention: Reserved for complications:
   • Splenectomy: Required for splenic rupture, uncontrolled hemorrhage, or secondary infection (abscess).
   • Percutaneous Drainage: For organized abscesses.

Risks and Complications

• Splenic Abscess: The necrotic tissue serves as a nidus for bacterial infection.
• Splenic Rupture: Rare, but life-threatening; typically occurs in patients with pre-existing splenomegaly.
• Pseudocyst Formation: Chronic complication of liquefaction.

Long-Term Prognosis

The prognosis is excellent for small, localized infarcts. The long-term outlook is primarily determined by the severity of the underlying systemic disease (e.g., the management of the underlying atrial fibrillation or hematologic malignancy). Patients who undergo splenectomy require lifelong vaccination (against encapsulated organisms like S. pneumoniae, N. meningitidis, and H. influenzae) and prophylactic antibiotics.

6. Massive FAQ Section

Q1: Is splenic infarction always painful?

No. Small, peripheral infarcts can be entirely asymptomatic and are often found incidentally during abdominal imaging for other reasons.

Q2: What is the most common cause of splenic infarction?

Embolic events from the heart, particularly in patients with atrial fibrillation or valvular heart disease, are the most frequently cited causes.

Q3: Why does my shoulder hurt if the spleen is in my abdomen?

This is known as Kehr’s sign. The spleen is located immediately beneath the diaphragm. Irritation of the splenic capsule causes referred pain to the left shoulder via the phrenic nerve (C3-C5).

Q4: Does splenic infarction require surgery?

Rarely. Most cases are managed conservatively with pain management, hydration, and treatment of the underlying cause. Surgery is reserved for rupture or abscess.

Q5: Can I live without a spleen?

Yes. Humans can survive without a spleen (asplenia), but they are at a higher risk of overwhelming post-splenectomy infection (OPSI). Vaccination is mandatory.

Q6: How is it different from a splenic abscess?

An infarction is a lack of blood flow leading to tissue death; an abscess is an active, pus-filled infection. They can overlap, as an infarct can become infected.

Q7: What blood tests should be ordered?

A full blood count (CBC), coagulation profile (PT/PTT/INR), LDH levels, and potentially a hypercoagulability panel (if no obvious cause is found).

Q8: Is it a life-threatening emergency?

In most cases, no. However, it can be a sign of a life-threatening underlying condition, such as undiagnosed endocarditis or a severe hematologic malignancy.

Q9: Can pregnancy cause splenic infarction?

There is a slightly increased risk during pregnancy due to the hypercoagulable state associated with gestation and the mechanical pressure of the gravid uterus, though it remains rare.

Q10: What is the role of anticoagulation?

Anticoagulation is used to prevent further emboli or to treat underlying thrombus formation. It is not used to "reverse" the existing infarct, as the damaged tissue is already necrotic.

7. Clinical Summary Table: Quick Reference

8. Conclusion

Splenic infarction serves as a critical "sentinel" diagnosis. While the infarction itself is often self-limiting, the diagnostic imperative lies in identifying the precipitating systemic pathology. Whether it is an undiagnosed arrhythmia, a hematologic disorder, or a systemic infection, the clinician must look beyond the spleen to ensure the patient receives comprehensive care. Through modern imaging and a structured diagnostic approach, the management of this condition has shifted from surgical intervention toward precise, targeted medical therapy, significantly improving patient outcomes.